Are vascular calcification and bone loss linked disorders of aging?

Are vascular calcification and bone loss linked disorders of aging?
Credit: International Osteoporosis Foundation

Vascular calcification, low bone mass and fragility fractures are all frequent age-dependent disorders. Recent clinical and experimental data suggest that vascular calcification and bone loss could share pathophysiological mechanisms.

A new review published by the International Osteoporosis Foundation (IOF) Working Group on Bone and Cardiovascular Diseases elucidates the numerous shared by the two disorders, identifying the following key associations:

  • Vascular is an active process of calcium and phosphate precipitation that involves the transition of the vascular smooth muscle cells (VSMCs) into osteoblast-like cells.
  • Among the molecules involved in this process, (PTH) plays a key role, acting through several mechanisms which include the regulation of the RANK/RANKL/OPG system and the Wnt/ß-catenin pathway, the main pathways for resorption and bone formation, respectively.
  • Some microRNAs have been implicated as common regulators of bone metabolism, vascular calcification, left ventricle hypertrophy and myocardial fibrosis.

Professor Jorge B. Cannata-Andia, lead author and Co-chair of the IOF Working Group on Bone and Cardiovascular Diseases, stated:

"This review consolidates current knowledge on how the pathogenesis and progression of vascular calcification and bone loss share several factors and pathways. This question remains: what comes first—is bone loss driving the vascular calcification or the opposite? Or, is there a higher level of dysregulation through aging processes that impacts on both tissues simultaneously but through similar mechanisms?"

In its summary and conclusions, the Working Group underscores the fact that the increase or decrease in tissue and/or serum levels of PTH, the RANK/RANKL/OPG system and the Wnt/bcatenin pathways, calcium, phosphate, FGF23, among the most studied factors, may play a pathogenic role but can also be used as markers of bone and cardiovascular diseases. However, levels of some serum markers should be interpreted with caution, as the correlation between hormone levels and tissue levels needs to be better investigated.

Professor Serge Ferrari, Co-chair of the IOF Working Group and Vice-Chair of the IOF Committee of Scientific Advisors, concluded:

"Better understanding of the shared mechanisms between aging, , and may ultimately help us to better understand the potential effects of drugs on the cardiovascular system. We hope that this review serves to clarify and summarize current knowledge on the pathophysiology of these common mechanisms, as a stepping stone to further research."

The research was published in Nutrients.

More information: Jorge B. Cannata-Andía et al, Pathophysiology of Vascular Calcification and Bone Loss: Linked Disorders of Ageing?, Nutrients (2021). DOI: 10.3390/nu13113835

Citation: Are vascular calcification and bone loss linked disorders of aging? (2021, November 15) retrieved 22 February 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Hormone and bone tests may be indicative of dialysis patients' heart health


Feedback to editors